TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.” July 21, 2006
TCL Archive Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing November 1, 2012
TCL Archive NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review June 2, 1978
TCL Archive Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says April 27, 1979
